Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Serious shortage protocol for fluoxetine 40mg extended

The Department of Health and Social Care (DH) has extended the serious shortage protocol (SSP) for fluoxetine 40mg capsules until August 10.

The SSP, announced on May 20, was set to expire yesterday (July 20). However, the protocol has been extended and will now end on August 10, the Pharmaceutical Services Negotiating Committee (PSNC) said last week (July 16).

Under the protocol, pharmacists will be able to supply an alternative of two fluoxetine 20mg capsules for every fluoxetine 40mg capsule they need to replace.

The reimbursement is “for the medicine supplied in accordance with the SSP and not the originally prescribed medicine”, the PSNC said.

“Supply in accordance with the SSP will result in the following fees being paid to the contractor: one single activity fee (currently £1.27) [and] one SSP fee (£5.35),” it explained.

“This expiry date may be brought forward or extended, and the content may be amended throughout this period. Pharmacists should ensure they are using the current version of an SSP before supplying an alternative product,” the PSNC added.

Have you had to use the SSP for fluoxetine 40mg?

Related Content


Pharmacist Manager
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts